Literature DB >> 24978929

Whole genome sequencing to identify host genetic risk factors for severe outcomes of hepatitis a virus infection.

Dustin Long1, Oren K Fix, Xutao Deng, Mark Seielstad, Adam S Lauring.   

Abstract

Acute liver failure is a severe, but rare, outcome of hepatitis A virus infection. Unusual presentations of prevalent infections have often been attributed to pathogen-specific immune deficits that exhibit Mendelian inheritance. Genome-wide resequencing of unrelated cases has proven to be a powerful approach for identifying highly penetrant risk alleles that underlie such syndromes. Rare mutations likely to affect protein expression or function can be identified from sequence data, and their association with a similarly rare phenotype rests on their existence in multiple affected individuals. A rare or novel sequence variant that is enriched to a significant degree in a genetically diverse cohort suggests a candidate susceptibility allele. Whole genome sequencing of ten individuals from ethnically diverse backgrounds with HAV-associated acute liver failure was performed. A set of rational filtering criteria was used to identify genetic variants that are rare in the population, but enriched in this cohort. Single nucleotide polymorphisms, insertions, and deletions were considered and autosomal dominant, autosomal recessive, and polygenic models were applied. Analysis of the protein-coding exome identified no single gene with putatively deleterious mutations shared by multiple individuals, arguing against a simple Mendelian model of inheritance. A number of rare variants were significantly enriched in this cohort, consistent with a complex and genetically heterogeneous trait. Several of the variants identified in this genome-wide study lie within genes important to hepatic pathophysiology and are candidate susceptibility alleles for hepatitis A virus infection.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute liver failure; genome-wide; hepatitis A; host genetics; immunity; viral hepatitis

Mesh:

Year:  2014        PMID: 24978929      PMCID: PMC4374731          DOI: 10.1002/jmv.24007

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

1.  Inapparent infection of hepatitis A virus.

Authors:  N Y Yang; P H Yu; Z X Mao; N L Chen; S A Chai; J S Mao
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

Review 2.  Glypicans.

Authors:  Lars-Ake Fransson
Journal:  Int J Biochem Cell Biol       Date:  2003-02       Impact factor: 5.085

Review 3.  The role of heparan sulphate in inflammation.

Authors:  Christopher R Parish
Journal:  Nat Rev Immunol       Date:  2006-08-18       Impact factor: 53.106

Review 4.  What did we learn from the Shanghai hepatitis A epidemic?

Authors:  W G Cooksley
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

5.  Two siblings with fulminant viral hepatitis A: case report.

Authors:  Mehmet Yalniz; Hüseyin Ataseven; Selman Celebi; Orhan Kürşat Poyrazoğlu; Nusret Sirma; Ibrahim Halil Bahçeitoğlu
Journal:  Acta Medica (Hradec Kralove)       Date:  2005

6.  Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States.

Authors:  I R Willner; M D Uhl; S C Howard; E Q Williams; C A Riely; B Waters
Journal:  Ann Intern Med       Date:  1998-01-15       Impact factor: 25.391

7.  Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis.

Authors:  Noriko Tsuchiya; Katsutoshi Tokushige; Naoko Yamaguchi; Kiyoshi Hasegawa; Etsuko Hashimoto; Katsumi Yamauchi; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2004-09       Impact factor: 7.527

8.  Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes.

Authors:  Ryan M Taylor; Timothy Davern; Santiago Munoz; Stephen-Huy Han; Brendan McGuire; Anne M Larson; Linda Hynan; William M Lee; Robert J Fontana
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

9.  Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.

Authors:  Heidi Barth; Christiane Schafer; Mohammed I Adah; Fuming Zhang; Robert J Linhardt; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Toshihiko Toida; Toin H Van Kuppevelt; Erik Depla; Fritz Von Weizsacker; Hubert E Blum; Thomas F Baumert
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

10.  Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.

Authors:  Jessica Matta; Myriam Baratin; Laurent Chiche; Jean-Marie Forel; Céline Cognet; Guillemette Thomas; Catherine Farnarier; Christelle Piperoglou; Laurent Papazian; Damien Chaussabel; Sophie Ugolini; Frédéric Vély; Eric Vivier
Journal:  Blood       Date:  2013-05-17       Impact factor: 22.113

View more
  3 in total

Review 1.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

Review 2.  Human genetic basis of fulminant viral hepatitis.

Authors:  Emmanuelle Jouanguy
Journal:  Hum Genet       Date:  2020-04-13       Impact factor: 4.132

3.  Clinical, serological and epidemiological features of hepatitis A in León, Nicaragua.

Authors:  Sophie Jaisli; Orlando Mayorga; Nadia Flores; Sandra de Berti; Gustav Frösner; Christian Herzog; Marcel Zwahlen; Sereina A Herzog
Journal:  PeerJ       Date:  2021-06-21       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.